Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

ITAAN Pharma and ACIC Pharmaceuticals Form Strategic Joint Venture Partnership


News provided by

ITAAN PHARMA INC.

Dec 05, 2023, 04:06 ET

Share this article

Share toX

Share this article

Share toX


ITAAN Pharma and ACIC Pharmaceuticals join forces in a strategic venture to advance generic injectables for the North American market. The collaboration is for enhanced product development and manufacturing excellence, resulting in a comprehensive range of critical injectable products. The partnership aims to swiftly introduce essential products, aligning with US FDA standards and addressing the escalating demand for reliable access to life-saving medicines. With a shared commitment to innovation, the ITAAN-ACIC collaboration heralds a new era of growth in injectable manufacturing capabilities.

FREDERICK, Md., Dec. 5, 2023 /PRNewswire-PRWeb/ -- ITAAN Pharma Inc. ("ITAAN"), a developer and manufacturer of specialty injectable formulations, has announced a significant joint venture agreement with ACIC Pharmaceuticals Inc. ("ACIC"), a well-established North American finished pharmaceutical and fine chemical company operating since 1973.

Dr. Ajay Pazhayattil, Partner at ITAAN, expressed gratitude for the opportunity to forge a long-term association with ACIC, a collaboration facilitated by Mr. Luciano Calenti, a recognized authority in the generic industry. ITAAN specializes in developing generic injectables, focusing on niche patient-critical products for regulated markets. "ITAAN is a North American-owned injectable business driven by industrial pharmacy professionals with in-depth knowledge of complex sterile product development and launch strategies," Dr. Pazhayattil highlighted.

"This partnership comes at a critical juncture with an increased need for access to lifesaving medicines and supply chain reliability," - Mr. Luciano Calenti, Founder & CEO at ACIC Pharmaceuticals.

Post this

The recently completed commercial facility complements ITAAN's state-of-the-art R&D capabilities. The facility's design enables seamless technology transfer from research and development to commercial production, aligning with FDA expectations for harnessing formulation development, process development and manufacturing science knowledge. ITAAN anticipates a rapid progression in its product development pipeline, aiming to promptly introduce a broader range of essential products to benefit medical professionals and patients within the next five years. These newly developed ANDA/ANDS products are designed to cater to the needs of both the US and Canadian markets.

Mr. Luciano Calenti, Founder & CEO at ACIC Pharmaceuticals, shared his optimism: "The ITAAN-ACIC partnership, we believe, will deliver value to ACIC injectable customers as we bring critical injectable products to the US and other markets. This partnership comes at a critical juncture with an increased need for access to lifesaving medicines and supply chain reliability." Mr. Calenti, a founder member of the Association of Accessible Medicines (AAM) and recipient of the AAM Lifetime Achievement Award, brings vast industry experience and expertise in patent legislation and has been a foundational member of the Canadian Drug Manufacturers' Association (CDMA).

This collaboration combines both organizations' extensive market knowledge, regulatory prowess, manufacturing excellence, and innovative capabilities. It presents a forward-thinking commercial strategy and a comprehensive array of injectable products.

Chandu Kankanala, Director at ITAAN, emphasized the synergy between the two entities, underlining the shared values and commitment to offering unique and distinctive products and services. He expressed excitement about tapping into the collective expertise of both organizations, envisioning that this partnership will propel a new phase of growth by enhancing injectable manufacturing capabilities and broadening the product range.

About ACIC Pharmaceuticals

ACIC Pharmaceuticals is a well-established pharmaceutical company providing a wide range of services, including Active Pharmaceutical Ingredients (API), Injectable Pharmaceutical Products, Pharmaceutical Machinery, Specialty Pharmaceuticals, and Electronic CTD Filing directly to the FDA. With a history spanning over four decades, ACIC Pharmaceuticals has consistently been a leader in supplying products and services to the pharmaceutical sector. For more information, visit ACIC Pharmaceuticals.

About ITAAN Pharma

ITAAN Pharma Inc. is a specialized pharmaceutical company focused on developing and commercializing injectable pharmaceuticals tailored for regulated markets. The company possesses robust capabilities in commercial manufacturing, including terminal sterilization, lyophilization, and aseptic filling, utilizing advanced filling lines for glass and PP vials. The dedicated R&D facility and team support product conceptualization to commercialization. For more information, visit ITAAN Pharma.

Media Contact

Media, ITAAN PHARMA INC., 1 4385261975, [email protected], itaanpharma.com

SOURCE ITAAN PHARMA INC.

Modal title

News Release
View PDF
News Release
News Release

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.